BioCentury | Jul 10, 2018
Distillery Techniques

Drug delivery

...June 25, 2018 doi:10.1073/pnas.1722338115 CONTACT: Samir Mitragotri, Harvard University, Cambridge, Mass. email: mitragotri@seas.harvard.edu Claire Quang 10x Genomics Inc. 14 alpha-sterol demethylase Ankylosing...
BioCentury | Apr 11, 2017
Distillery Techniques

Drug properties; other

...8, 2017 doi:10.1124/jpet.117.240523 CONTACT: Nina Isoherranen, University of Washington, Seattle, Wash. email: ni2@u.washington.edu Hongjiang Li University of Washington 14 alpha-sterol demethylase Cytochrome...
BioCentury | Aug 3, 2015
Clinical News

Cresemba isavuconazonium: Phase III data

...Inc. (Tokyo:4503), Tokyo, Japan Product: Cresemba isavuconazonium (isavuconazole) ( BAL8557 ) Business: Infectious Molecular target: 14 alpha-sterol demethylase...
BioCentury | Nov 17, 2014
Clinical News

Isavuconazole regulatory update

...Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Product: Isavuconazole ( BAL8557 ) Business: Infectious Molecular target: 14 alpha-sterol demethylase...
BioCentury | Oct 27, 2014
Clinical News

Isavuconazole: Phase III ongoing

...Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Product: Isavuconazole ( BAL8557 ) Business: Infectious Molecular target: 14 alpha-sterol demethylase...
BioCentury | Oct 7, 2013
Clinical News

Isavuconazole: Phase III data

...Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Product: Isavuconazole ( BAL8557 ) Business: Infectious Molecular target: 14 alpha-sterol demethylase...
BioCentury | Jul 29, 2013
Clinical News

Isavuconazole: Phase III

...Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Product: Isavuconazole ( BAL8557 ) Business: Infectious Molecular target: 14 alpha-sterol demethylase...
BioCentury | Jul 22, 2013
Clinical News

Isavuconazole: Phase III amended

...and VITAL are expected this half. Product: Isavuconazole ( BAL8557 ) Business: Infectious Molecular target: 14 alpha-sterol demethylase...
Items per page:
1 - 8 of 8